News
- Author:
- Liam Davenport
Publish date: June 9, 2022
Had psychiatrists who treated patients in the study known about their metabolizing profiles, it “might have contributed to switches in medication” ...
News
- Author:
- Liam Davenport
Publish date: June 8, 2022
“We don’t know if these effects will result in any longer-term issues,” but longer-term observation “may help us understand this.”
News
- Author:
- Liam Davenport
Publish date: June 6, 2022
In the U.S., the choice between an anti-EGFR or anti-VEGF antibody for colorectal cancer has been controversial.
News
- Author:
- Liam Davenport
Publish date: June 4, 2022
A new drug under study for patients with pancreatic cancer targets EGFR leading to one-year survival rates of 43.6% for patients.
Article
- Author:
- Liam Davenport
Publish date: June 3, 2022
Phase 3 SHINE study of older patients with mantle cell lymphoma yields “profound” results with ibrutinib add-on.
News
- Author:
- Liam Davenport
Publish date: June 1, 2022
Researchers have developed a novel app to show how the increased risk of coronary events due to elevated lipoprotein(a) levels can be countered by ...
News
- Author:
- Liam Davenport
Publish date: May 11, 2022
“Experts call for “nuanced” prescribing of proton pump inhibitors to patients with cirrhosis in study that found lower mortality only in those with...
News
- Author:
- Liam Davenport
Publish date: May 6, 2022
The “misconception regarding the predictive value of these tests on chemotherapy benefits suggest there is still room for training on results inter...
News
- Author:
- Liam Davenport
Publish date: April 25, 2022
Researchers found the most common first treatment switch, in 17.9% of patients, was from olanzapine to aripiprazole.
News
- Author:
- Liam Davenport
Publish date: April 25, 2022
Results of a 12-week study showed a significant difference in percent change in body weight from baseline between two treatment groups.
News
- Author:
- Liam Davenport
Publish date: April 22, 2022
The rate of postoperative infection is no different between patients exposed to and those unexposed to tumor necrosis factor inhibitors in the 12 w...
News
- Author:
- Liam Davenport
Publish date: April 19, 2022
New CLL drug demonostrates its efficacy in the crowded field of CLL treatment options.
News
- Author:
- Liam Davenport
Publish date: April 15, 2022
New research suggests that “semantic speech networks can enable deeper phenotyping of formal thought disorder and psychosis.”
News
- Author:
- Liam Davenport
Publish date: April 14, 2022
Monthly injections were associated with a fivefold prolongation of time to impending relapse in comparison with placebo.
News
- Author:
- Liam Davenport
Publish date: April 13, 2022
Many previous trials in this area have failed, but it may be important to study patients relatively early in their disease course.
